# XWELL, Inc. (XWEL)

> Source: Nexqual · https://nexqual.com/XWEL · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, XWELL, Inc. (XWEL), nexqual.com/XWEL" · informational, not investment advice.

**Price:** USD 0.75 (+2.40% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 0.73 · day 0.69–0.75 · 52w 0.26–2.2 · market cap $7.5M · NCM

## Key facts
- Total return with dividends: 1Y -25.0% vs S&P 500 +18.1%; 5Y -97.3% vs S&P 500 +85.1%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -25.0% | -97.3% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -25.1% | -51.5% |
| Volatility (annualized) | 153.0% | 98.0% |
| Max drawdown | -71.0% (Oct 2025→Jan 2026) | -99.2% (Dec 2021→Jan 2026) |

## Peers (Diagnostics & Research)
MYGN (Myriad Genetics, Inc.) USD 4.35 +6.62% · FLGT (Fulgent Genetics, Inc.) USD 21.34 +1.33% · CSTL (Castle Biosciences, Inc.) USD 33.8 +2.80% · OPK (Opko Health, Inc.) USD 1.61 +21.97% · FRNM (Freenome, Inc.) USD 12.29 -2.81% · PSNL (Personalis, Inc.) USD 15.93 +0.50%

## More
Full page: https://nexqual.com/XWEL · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt